ArticleMedicine2026
Mechanism prediction of Wenjing Tongluo Powder for post-laparoscopic shoulder pain: A network pharmacology study.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
This study aimed to predict the pharmacological mechanisms of Wenjing Tongluo Powder (WTP) in relieving post-laparoscopic shoulder pain (PLSP) using network pharmacology, and to provide prioritized candidate targets and pathways for future experimental validation. Active ingredients of WTP were screened from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform database using ADME criteria (oral bioavailability ≥ 30%, drug-likeness ≥ 0.18). Their potential targets were predicted via the SwissTargetPrediction database. PLSP-related targets were retrieved from disease databases (Online Mendelian Inheritance in Man, therapeutic target database, etc). The intersecting targets were analyzed through protein-protein interaction network construction (using STRING and Cytoscape) to identify hub genes, followed by Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analyses. A total of 72 active ingredients and 546 potential targets of WTP were identified. 136 common targets intersected with PLSP-related targets. Protein-protein interaction network analysis highlighted COX-2, TNF-α, ESR1, EGFR, CASP3, BCL2, MAOA, MAOB, and PPARG as core targets. Gene Ontology analysis suggested involvement in processes like vascular regulation and G protein-coupled receptor activity. Kyoto Encyclopedia of Genes and Genomes enrichment analysis predicted that key pathways, including the calcium signaling pathway, cAMP signaling pathway, PI3K-Akt signaling pathway, and cGMP-PKG signaling pathway, may be crucial for the therapeutic effect. This network pharmacology study predicts that WTP may alleviate PLSP by modulating core targets (e.g., COX-2, TNF-α) and signaling pathways (e.g., PI3K-Akt). These findings provide a systemic mechanistic hypothesis and a focused direction for subsequent experimental studies to confirm the bioactivity and therapeutic relevance of these predictions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.